首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncotargets and therapy

缩写:ONCOTARGETS THER

ISSN:1178-6930

e-ISSN:1178-6930

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引6681
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Euis Julaeha,Faryanti Eka Mulyawan,Feby Marlia Anwar et al. Euis Julaeha et al.
Aim: Breast cancer remains a prevalent and challenging health issue for women globally. In the pursuit of more effective and less harmful therapies, researchers have focused on natural compounds, especially phenolic compo...
Yong Zhang,Hengliang Sun,Weibo Bo et al. Yong Zhang et al.
Objective: This study aims to integrate bulk and single-cell RNA sequencing data to construct a risk score model based on HOXC9-related immune genes (HRIGs) and evaluate its prognostic value in hepatocellular carcinoma (H...
Yixuan Wang,Lianru Zhang,Yanan Du et al. Yixuan Wang et al.
Purpose: Early relapsed breast cancer, characterized by recurrence within two years post-surgery, often results from drug resistance and rapid progression. The clinicopathological, prognostic and molecular features of the...
Chaochu Cui,Aiwei Yan,Shengming Huang et al. Chaochu Cui et al.
Cancer remains the foremost cause of mortality on a global scale. Immunotherapy has yielded remarkable outcomes in the fight against cancer and is regarded as one of the most crucial and promising therapeutic modalities. PCSK9, a critical t...
Liang Wen,Ping Wang,Guosheng Zhang et al. Liang Wen et al.
Introduction: Nicotinamide plays a critical role in the prevention and treatment of tumors, and its metabolism is closely associated with tumor progression. The aim of this study was to understand the prognostic and immun...
Asim Farooq,Aatif Amin,Shaarif Bashir et al. Asim Farooq et al.
Introduction: Osteosarcoma, a prevalent bone malignancy in children and adolescents, is currently treated through surgical resection and chemotherapy. Advancements in cancer research are targeting immune checkpoint molecu...
Hirokazu Iso,Makiko Yomota,Yukari Shirakura et al. Hirokazu Iso et al.
Purpose: Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. In the FLAURA trial, osimertinib demonstrated longer progression-free survival (PFS) and overall survival (OS) ...
Rafael Cerón Maldonado,Adolfo Martínez Tovar,Christian Omar Ramos Peñafiel et al. Rafael Cerón Maldonado et al.
Purpose: Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous aggressive lymphoid neoplasm. Cases of refractoriness and relapse persist in approximately 40% of patients treated with first-line R-CHOP regimen, thus, th...
Li Ning,Xiu Li,Yating Xu et al. Li Ning et al.
Background: Thousand and One Kinase 1 (TAOK1), a member of the MAPK kinase family, plays a crucial role in processes like microtubule dynamics, DNA damage response, and neurodevelopment. While TAOK1 is linked to tumorigen...
JiaQi Liu,Jun Chu JiaQi Liu
Background: Anaplastic thyroid cancer (ATC) is a rare, highly aggressive malignancy that accounts for less than 2% of thyroid cancers but contributes significantly to morbidity and mortality. Despite its rapid progression...